Back to News
Market Impact: 0.2
Addex Therapeutics Secures $2.8 Mln Via ATM Sale; Cash Runway Extended To Q4 2027;Stock Up
Source: Nasdaq
Healthcare & BiotechPrivate Markets & VentureCompany Fundamentals
Addex Therapeutics raised $2.8 million in gross proceeds by selling 0.44 million ADS under its at-the-market (ATM) offering (ADS representing 52.54 million shares). The financing provides incremental runway for the clinical-stage company, though the reported amount is modest and likely limits near-term share price impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
ADXN0.20
More News
- Addex (NASDAQ: ADXN) spin-out Neurosterix clears Phase 1, plans next stage
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- Bank of America is bullish on these top stocks ahead of earnings
- As companies pour billions into Earth-based AI infrastructure, Google is taking the data center race off-planet
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant